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ABSTRAK 
 
 
Keupayaan tumbuh-tumbuhan ubatan melawan mikroorganisma patogenik 
telah menyebabkan ramai saintis mengasingkan sebatian aktif dan seterusnya 
mengkaji mekanisme tumbuhan ini. Ini adalah penting untuk melawan kejadian 
patogen yang rintang dadah. Dalam kajian ini, tumpuan adalah untuk mencari agen 
antikulat baru dari alkaloid Rutaceae. Pengasingan berpandukan biocerakian telah 
dilakukan untuk mengasingkan alkaloid aktif antikulat. Kesan alkaloid ini terhadap 
gen yang disasarkan telah dipilih dan diperhatikan dalam kajian ini melalui analisis 
kuantitatif rantai polimerase masa nyata (qRT-PCR). Daun dari tumbuhan Ruta 
angustifolia (L.) Pers. telah diekstrak dan difraksikan dengan menggunakan teknik 
kromatografi. Melalui pengasingan biocerakian, gabungan fraksi H3-3 dan H4-8, 
H10-9 dan DA-10 telah menghasilkan sejumlah tiga alkaloid aktif antikulat. Alkaloid 
yang telah diasingkan kemudiannya dikenalpasti melalui profil Kromatografi 
Lapisan Nipis, suhu takat lebur dan gelombang maksimum untuk penyerapan UV 
dalam metanol (UVλ max-MeOH) berbanding piawai alkaloid. Pengenalpastian 
selanjutnya disahkan oleh data spektroskopik HPLC (High Performance Liquid 
Chromatography) dan NMR (Nuclear Magnetic Resonance) telah dicirikan sebagai 
acridone, furoquinoline dan 4-quinolone, masing-masing dikenali sebagai arborinine, 
skimmianine dan graveoline. Aktiviti antikulat bagi ketiga-tiga alkaloid ini telah diuji 
terhadap Candida albicans dan Candida glabrata dari rangkaian ATCC. Ujian 
xvi 
 
microdilusi alkaloid memberikan nilai kepekatan perencat minimum (MIC) antara 
250 μg/ml hingga 1000 μg/ml. Nilai Kepekatan Fungisidal Minimum (MFC) 
direkodkan pada 500 μg/ml dan 1000 μg/ml. Antibiotik fluconazole telah dipilih 
sebagai standard dalam kajian ini. Hasil daripada analisis qRT-PCR ke atas               
C. albicans menunjukkan bahawa arborinine mampu menurunkan kadar CDR1 dan 
gen ERG11. Sel yang dirawat dengan skimmianine menunjukkan penemuan yang 
lebih baik apabila kadar ekspresi ICL1, MLS1, MDR1 dan CDR2 berjaya diturunkan. 
Bagi sel-sel yang dirawat dengan graveolin, pengurangan ekspresi telah dikesan 
dalam gen CDR1, CDR2 dan ERG11. Analisis ke atas C. glabrata, sel yang dirawat 
dengan arborinine menunjukkan penurunan yang signifikan terhadap tiga gen yang 
disasarkan iaitu ICL1, PCK1 dan MLS1. Kesan Skimmianine dan graveoline ke atas 
ekspresi gen sel adalah sama apabila kedua-dua sebatian tersebut dapat menurunkan 
kadar ekspresi ICL1 dan PCK1. Kesan ke atas protin CaIcl1 di dalam C. albicans 
juga berjaya dikurangkan oleh tiga alkaloid aktif tersebut melalui teknik western 
blot.   Secara keseluruhannya, kami menyimpulkan bahawa aktiviti antikulat alkaloid 
yang diasingkan ini adalah komponen yang mempunyai potensi sebagai perencat 
ekspresi gen yang virulen dan gen rintangan ke atas C. albicans and C. glabrata.           
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ANTIFUNGAL ACTIVITIES OF THREE ALKALOIDS FROM                         
RUTA ANGUSTIFOLIA (L.) PERS AGAINST ATCC SUSCEPTIBLE 
STRAINS OF CANDIDA ALBICANS AND CANDIDA GLABRATA 
 
ABSTRACT 
 
 
The vital ability of medicinal plants to resist pathogenic microorganisms has 
led many scientists to isolate the active compounds and further investigate their 
mechanism of action. This is important as to fight the growing incidence of drug-
resistant pathogens. Overall, this study is focusing towards searching for new 
antifungal agent from alkaloids belong to Rutaceae family. The bioassay guided 
isolation was performed to isolate the antifungal active alkaloids. The impacts of 
these alkaloids on selected targeted genes have been experimented through 
quantitative real-time polymerase chain reaction (qRT-PCR). Leaves of the plant 
Ruta angustifolia (L.) Pers. was extracted and fractionated by using standard 
chromatographic techniques. Through bioassay-guided isolation, combined fraction 
of H3-3 and H4-8, fraction H10-9 and DA-10 yielded a total of three antifungal 
active alkaloids. These isolated alkaloids were then characterized and compared to 
the standard alkaloids by means of Thin Layer Chromatography (TLC) profile, 
melting point and maximum absorption of UV spectra in methanol (UVλ max-
MeOH). The identification was further confirmed by HPLC spectroscopic data and 
was characterized as acridone, furoquinoline and 4-quinolone so named arborinine, 
skimmianine and graveoline respectively. The antifungal activites of the three 
alkaloids were tested against Candida albicans and Candida glabrata of ATCC 
strains with that of the standard antibiotics fluconazole. Broth microdilution assay of 
xviii 
 
the alkaloids gave Minimum Inhibitory Concentration (MIC) values ranging from 
250 µg/ml to 1000 µg/ml. Minimum Fungicidal Concentration (MFC) values were 
recorded at 500 µg/ml and 1000 µg/ml. The results from qRT-PCR analysis in         
C. albicans revealed that arborinine, skimmianine and graveoline down regulate all 
genes related to the central metabolism of Candida which are PCK, ICL and MLS. 
However, in the regulation of resistant genes, there is a decreased in ERG11, CDR2 
and MDR after treated with arborinine, skimmianine and graveoline respectively. As 
in C. glabrata gene expression analysis, arborinine treated cells showed a significant 
decrease against three targeted genes namely ICL1, PCK1 and MLS1. Skimmianine 
and graveoline impact on the gene expression of the cell revealed the same impact 
when both of the compounds were able to down regulate ICL1 and PCK1 while MLS 
and ERG11 increased. The three isolated compounds were also able to reduce protein 
expression of Caicl1 in C. albicans through Western Blot. Overall, this study has 
proven that arborinine, skimmianine and graveoline can be remarkable component as 
antifungal agents with potential capacity to inhibit the growth and suppress the 
expression of the targeted genes and protein of C. albicans and C. glabrata.  
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CHAPTER 1.0: INTRODUCTION 
 
1.1. Problem Statement 
       Candida species are opportunistic fungal pathogens that have become the 
second most common responsible life-threatening infections worldwide (Liu et 
al. 2017). Over the past decade, the prevalence of candidiasis increased due to 
rising number of immunocompromising conditions including human 
immunodeficiency virus (HIV) infection, cancer, old age, endocrine disorders, 
radiotherapy, malignant diseases and other critical illnesses (Kaomongkolgit et 
al. 2009). Among the many Candida species, C. albicans has been reported as 
the most prevalent pathogen in both mucosal and systemic fungal infections 
(Pfaller et al. 2002) while C. glabrata is the second or third most isolated 
pathogen in patients with oral candidiasis (Fidel & Vazquez 1999). This is 
consistent with epidemiology report of fungal infections in an Infectious 
Disease Reference Centre (IDRC) in Malaysia, whereby increasing morbidity 
and mortality among hospitalized patients and immunocompromised 
individuals is a major factor in the emergence of opportunistic fungal 
infections with isolation frequency of 29.9% of Candida albicans and 3.9% of 
Candida glabrata (Tzar et al. 2013). A retrospective study were also evaluated 
on all cases of candidemia in Hospital Universiti Sains Malaysia (HUSM) 
among adult patient and collectively, C. albicans and C. glabrata were 
responsible for 20.1% of the distribution (Haydar 2018).    
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1.2 Significance of the Study 
Candida carriages a multitude of virulence attributes to its adaptability 
for growth (Nordin et al. 2013). One of the attributes is metabolic flexibility in 
which it enables Candida to survive in nutrient-limited host during infection. 
Among the metabolic pathways, glycolysis, gluconeogenesis and the 
glyoxylate cycle are the most studied and all thought to contribute to Candida 
survival (Cheah et al. 2014).  The key enzymes involve in those pathways are 
isocitrate lyase (ICL), malate synthase (MLS) and phosphoenolpyruvate Kinase 
(PCK). It has been suggested inhibitors of these enzymes should decrease 
survival of these pathogens inside macrophages (Lorenz & Fink 2001; Brown, 
Budge, et al. 2014). Therefore, the identification of this pathway as a target for 
antifungal compounds has potential applications in the development of new 
antifungal therapies.  
Besides the fitness attributes of Candida, the resistance in current 
antifungal agents also restricts the effectiveness in treating Candida. Drug 
resistance emerges due to widespread application of antifungal drugs for both 
preventive and therapeutic purposes (Cowen et al. 2015). Cellular and 
molecular mechanisms underlying antifungal drug resistance may include 
reduction of drug absorption due to increased drug efflux and mutations in 
genes of target protein, involving overexpression of candida drug resistance 
(CDR) and multidrug resistance (MDR) genes. In addition, presence of point 
mutations in ERG11 was also identified as the mechanism of resistance. 
ERG11 gene encodes the enzyme of 14-α-sterol demethylase which involves in 
the biosynthesis of the fungal membrane (Cowen et al. 2015; Whaley et al. 
2017).  
3 
 
Considering the above exceptional fitness attributes that Candida 
possesses to survive, development of new antifungal drugs are in crucial need 
as to fulfil the therapeutic resources which is limited in the spectrum of their 
activity (Shin et al. 2005) and reduce the incidence of drug-resistant fungi. As 
reported by Clinical and Laboratory Standard Institute, percent of resistant 
isolates in C. albicans and C. glabrata were 3.5% and 7.8% respectively 
(Whaley et al. 2017). One of the effort in developing new antifungal drugs is 
by utilizing secondary metabolites of natural plant products as a potential 
source for antifungal drugs with more effective and safe derivatives (Liu et al. 
2017).  Therefore, the present study was undertaken to isolate and identify the 
antifungal active alkaloids of R. angustifolia and evaluating their potential as 
gene inhibitors against the virulence genes namely ICL, MLS, PCK and the 
resistant genes which are CDR, MDR and ERG11 genes in C. albicans and                 
C. glabrata. The plant R. angustifolia was chose due to the antimicrobial 
bioautography-guided isolation of alkaloidal fractions of R. angustifolia leaves 
which led to the identification of a major antimicrobial active alkaloid 
identified as graveoline, together with arborinine, and the minor alkaloid, 
skimmianine (Zarisa, 2013; Zarisa et al. 2018). Belongs to the family of 
Rutaceae and genus of Ruta (rue), Ruta angustifolia is a main source of 
alkaloids derived from anthranillic acid precursors that promotes a 
pharmacologically active compound with antiasthmatic, anticancer, 
antibacterial and antifungal activities (Adamska-Szewczyk et al. 2016). The 
mechanism by which R. angustifolia mediate their biological activities has not 
been studied in great detail. Previous study on furoquinoline and 
pyranoquinolone alkaloids from Rutaceae have indicated that it targets a 
4 
 
specially designed 1.5kb DNA fragments, but the precise mechanism by which 
it inhibits which enzyme has not been established (Hanawa et al. 2004).  
In the present study, phytochemical screening was first applied through 
bioassay guided isolation of antifungal active alkaloids of Ruta angustifolia. 
This bioassay is a simple and easy technique to localize and isolate which 
alkaloid contained in the crude extract that exert an antifungal activity. Once 
isolated and elucidated, the targeted alkaloids were further identified by certain 
phytochemical analysis. The identified antifungal active alkaloids were then 
subjected to broth microdilution assay to quantify the antifungal activity. 
Lastly, the selected potential target genes of C. albicans and             C. 
glabrata were screened using the antifungal active alkaloid compound through 
quantitative real-time inhibitory polymerase chain reactions (qRT-PCR) and 
western blot to observe the up and down regulation of the genes and effects on 
its protein respectively.    
 
1.3  Hypothesis 
 
The anthranillic acid derived alkaloids of various structural types from 
Ruta angustifolia (L.) Pers. may possess antifungal activity and might 
downregulate the selected virulence and resistant genes and reduce CaIcl 
protein expression.             
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1.4 Objectives 
 
General Objective: 
This study is purposely done to identify the antifungal active alkaloids of        
R. angustifolia and to investigate its effect on virulence gene expression of         
C. albicans and C. glabrata.  
 
Specific Objectives:    
1) To extract and elucidate the antifungal active alkaloids isolated from the 
leaves of Ruta angustifolia (L.) Pers.  
2) To determine Minimum Inhibitory Concentration (MIC) and Minimum 
Fungicidal Concentration (MFC) of antifungal active alkaloids derived  
Ruta angustifolia against C. albicans and C. glabrata.    
3) To investigate the effect of the isolated antifungal active alkaloids on the 
expression of virulence genes (PCK1, ICL1, MLS1,) and resistant genes 
(ERG11, CDR1, CDR2 and MDR1) using qPCR analysis.   
4) To examine the impact of antifungal active alkaloid derived Ruta 
angustifolia on C. albicans (Caicl1) protein using western blot.        
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CHAPTER 2.0: LITERATURE REVIEWS 
 
2.1 Plants as Potential Source of Antifungal Agent.   
 
 Nature is the source of medicine, and a huge number of modern drugs 
have been isolated from the natural sources used in traditional medicine 
(Ghorbani et al. 2006). In Peninsular Malaysia itself, more than 1300 medicinal 
plant species have been document (Sultana et al. 2014) and most of them have 
involved in multidimensional study combining botanical, phytochemical, 
biological, and molecular (Balunas & Kinghorn 2005). It has been estimated 
that 14 to 28% of higher plant species which are traditionally used as medicine, 
74% of those plant are pharmacologically active (Ncube et al. 2008). Plus, 
around 119 bioactive compounds from 90 plants were originally used as single 
entity medicinal agent, which means a specific secondary metabolite were 
extracted and are utilized with established application for instance caffeine is 
use as stimulant (Pan et al. 2013). Out of this 90 plants,  77% were initiate by 
ethno medical screening  (Ghorbani et al. 2006).   
Antifungal drugs originated from natural sources were found to be 
significantly increasing due to the treatment failure or recurrence fungal 
infections reported in oral (Darwazeh & Darwazeh 2014)  and vaginal 
candidiasis (Belayneh et al. 2017). Besides, increasing incidence of drug-
resistance also has led to the challenges in prevention and treatment of fungal 
infections (Hani et al. 2015). Based on ethnopharmacognosy research, a wealth 
of experience on the application of herbal in drugs discovery is due to its long-
term history of utilization by human and are likely to be safe and less adverse 
effect (Sasidharan et al. 2011). In addition, as human beings eat both plants and 
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meats,  plant-derived medicines may interact favourably with the human body 
and hence produce beneficial effects in terms of health promotion (Pan et al. 
2013). The unlimited source of significant, complex and stable chemical 
structures that plants provided would never be the subject of synthetic 
establishment. Thus, the structural diversity that is still largely untapped can be 
guaranteed (Veeresham 2012).  
Another reason that have increased the importance of medicinal plants is 
that the plants are relatively cheap source (Arif et al. 2009). Compared to 
average prescription drug price, herbal medicines are more affordable to the 
lower income group. However, some herbal products are quite expensive 
nowadays because consumers are also paying for the so-called research and 
development by the company involved in synthesizing the active compounds 
from its main ingredients (Krause & Tobin 2013). This also contribute to the 
availability of information about herbal medicines and have increased the trend 
of consuming them. Since 1997, herbal medicine sales in the United States 
reaching an estimated total of about US$3.24 billion (~RM12.3 billion). 
Malaysians spent about RM2.0 billion on herbals which amounts to about 
RM45.00 spent on herbals per person per year in the United States by 
comparison to about RM91.00 per person per year in Malaysia taking into 
account populations of 273 million and 22 million respectively. This figures 
the potential of the herbal market in our country (Hussin 2001).     
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2.2 Major groups of Antifungal Compounds from Plants 
 
As biological material, plant is carrying a vast variety primary and 
secondary metabolites which can be selected as the molecule with desired 
biological activity (Arif et al. 2009). Primary metabolites in plants is 
fundamentally synthesized through pathways that generally modify and 
produce carbohydrates, proteins, fats, and nucleic acids that governs all basic 
physiological that allow plant growth, development and reproduction (Nwokeji 
et al. 2016). In contrast, secondary metabolite basically derived through several 
interacting metabolic pathways which also depends on primary processes 
which include tricarboxylic acid cycle (TCA), methylerithrotol phosphate 
(MEP) pathway, mevalonic and shikimic acid pathway (Wang et al. 2016).  
There are three groups of secondary metabolites namely Terpenes, Phenolic 
compounds and Nitrogen-containing compounds. Note that, the importance of 
these metabolites are due to their role in antimicrobial, pharmaceuticals, plant 
defence against herbivory, fragrance, stimulants, toxicity, attractant, plant 
breeding, physiological stress response, and allelopathtic effect (Nwokeji et al. 
2016). They were also probably evolved from plants purposely for chemical 
defense against predation or infection (Satish et al. 2008). Of all the three 
classified group of the secondary metabolites, our focus is on the nitrogen-
containing compound which is alkaloid. The plant of interest in the present 
study which belongs to Rutaceae family, has been a great source of anthranillic 
acid derived alkaloids with biologically active antibacterial and antifungal 
properties (Adamska-Szewczyk et al. 2016).  
A few studies have been carried out on the antifungal activity of 
alkaloids of natural origin. These include plant-derived aporphinoid alkaloids 
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namely eupolauridine and liriodenine that exhibit potent inhibitory activity 
against the opportunistic fungal pathogens Candida albicans and 
Cryptococcus neoformans (Tripathi et al. 2017). Another isolated alkaloid 
was successfully identified as 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-
methylethylpentanoate from the plant Datura metel, showed a great activities  
both in vitro and in vivo against Aspergillus and Candida species (Dabur et al. 
2005). An isoquinoline alkaloid known as berberine was also reported to be 
an antifungal alkaloid against C. albicans and non-albicans Candida species 
with variable susceptibilities. Notably, berberine also was reported to be non-
toxic to human cells (Dhamgaye et al. 2014).   
 
2.3    Ruta angustifolia (L.) Pers 
 
The Rutaceae family has about 140 genera, grow in all parts of the 
world consisting of herbs, shrubs and small trees (Riyanto et al. 2001; Sandjo 
et al. 2014). Belongs to the family of Rutaceae and genus of Ruta (rue),       
Ruta angustifolia (L.) Pers, Figure 2.1 (a) is a medicinal plant which originates 
from Southern Europe and North Africa. According to CRC World Dictionary 
of Medicinal and Poisonous Plant, this plant was identified by Swedish 
biologist, Carolus Linnaeus in 1805 and later by Christiaan Hendrick Persoon 
(2010). R. angustifolia is said to be the diffusion of other species which is                    
R. chalepensis. Significantly, this species has been abundantly consumed in the 
most ancient systematic record of medical practice of the Mediterranean world 
(Pollio et al. 2008).  
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 Figure 2.1 (a) Ruta angustifolia (whole plant) and (b) (The leaves) 
The plant often grows up to 1.5 m height with slender woody stems and 
light green leaves with very strong foetid odour  (Richardson et al. 2016) . The 
leaves of Ruta angustifolia Figure 2.1 (b) are in spiral arrangement crenate, 
narrow or oval leaves, 2–3 times divided into segments oblong and ciliate-
fringed sepals. It is well grown on preferably well-drained calcareous clayey 
soil under fair dry conditions and partial shade (Kannan & Babu 2012).         
This plant is used traditionally for treating snake bites and parasites, 
stomatitis, rheumatism and bronchitis (Sandjo et al. 2014). In many parts of the 
world, the leaves will be first heated to boil before they consumed or used it as 
medicine. Based on this healing ability, several pharmacological activities were 
later proved by this plant includes antioxidant, analgesics, anti-cancer (Shuib et 
al. 2015; Richardson et al. 2016) and antifungal activities (Ncube et al., 2008). 
Therefore, it is necessary to focus and develop bioactive compounds of this 
plant as a potential drugs target against Candida.   
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2.3.1 Alkaloids of Ruta Species 
 
          Alkaloids are a group of important secondary metabolite. This substance 
are presence in more than 15,000 nitrogen containing secondary metabolites 
which is approximately 20% of the species of vascular plant (Kennedy & 
Wightman 2011). Nitrogen atom in these substances is usually part of the 
heterocyclic ring, a ring that comprise both nitrogen and carbon atom 
(Nwokeji et al. 2016). Alkaloids in the Ruta species were completely to be 
derived from amino acids precursors, anthranillic acid particularly which 
possess quinoline and acridine skeletons (Figure 2.2) (Basco et al. 1994; 
Nugroho et al. 2010).   
 
CO2H
NH2  
   Anthranillic acid (1)                       
N  
    Quinoline (2)              
N  
   Acridine (3) 
Figure 2.2 Alkaloids derived from anthranillic acid (1) which gives rise to 
quinoline (2) and acridine (3) (Riyanto et al. 2001).  
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Acridine origin, is basically one of the biochemical pathways which 
involves condensation of anthranillic acid (1) and acetate or malonate 
(Figure 2.3). The extension of N-methyl anthraniloyl-CoA chain’s (4) three 
malonate units were integrated with lead to form polyketide (5). The Claisen 
condensation plays a role in nucleophilic addition, dehydration as well as the 
C-N linkage. This way, acridine skeleton was formed which bring a stable 
aromatic tautomer (8).  Acridone alkaloids are found exclusively in plants 
belonging to the Rutaceae family and have been proven as anticandidiasis and 
antiplasmodium agent (Lukačin et al. 1999).  
 
COSCoA
 NHMe
N-methyl anthraniloyl CoA(4)
3x malonyl-CoA 
HN
Me
O O
O
O
CoAS
Claisen
reaction
O
NHMe
O O
O
Nucleophilic
addition
NMe O
O  O
OH
Dehydration and
enolization to form
aromatic ring.
- H2O
NMe OH
 O OH
1,3-dihydroxy-N-methylacridone 
(5)
(6)
(7)
(8)  
Figure 2.3 Biosynthetic pathway of acridone (Paul 2002). 
 
Anthraniloyl-CoA (9) is the starter unit in chain extension via one 
molecule of malonyl-CoA. This will lead to amide formation and later 
produces the heterocyclic system comprising of di-enol tautomer (12). 
Finally, more stable 4-hydroxy-2-quinolone (13) were formed (Figure 2.4) 
(Paul 2002).     
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COsCoA
NH2
anthraniloyl-CoA (9)
malonyl-CoA
O   
O
SCoANH2
   amide
formation 
NH O
O
N OH
OH
NH
OH
O
4-hydroxy-2-quinolone (13)  
     
 di-enol tautomer
(10) (11)
(12)  
Figure 2.4 Biochemical pathway of 4-hydroxy-2-quinolone (13) (Paul 2002).  
 
 Two and 4-quinolones are among the derivatives of rutaceae alkaloids 
including furoquinoline and acridones. These quinolone alkaloids contribute 
to more pharmacological active substance isolation which is aryl-, alkyl- as 
well as alkylarylquinolone/ines. Hydroxyl group on carbons is adjacent to the 
nitrogen ring in the stable quinolone structure (13). In figure 2.5, 2-
hydroxyquinolines and 4-hydroxyquinolines were formed through the camps 
cyclization which depends on exact starting materials and reaction conditions. 
Pairing of quinolines hydroxyl-substitutions was commonly known as 2-
quinolones. 2-quinolones, the oxygen is a neighbour to N-ring while in 4-
quinolone, the oxygen located crossly from the N-ring  (Adamska-Szewczyk et 
al. 2016).  
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NH
 O
R
O
-OH
N
 R  
 OH
+   
N
R
OH
 
   4-Quinolone 2-Quinolone
(14)
(15) (16)
 
Figure 2.5 Formation of 4-quinolone (15) and 2-quinolone (16) (Abdou 2014).   
 
It is highly nucleophilic by looking at position three of 4-hydroxy-2-
quinolone structure. When dimethylallyl diphosphate took place, this is where 
alkylation is susceptible. As a results additional six- and five-membered 
oxygen heterocyclic rings will formed. To form furoquinoline alkaloids 
(figure 2.6) for example skimmianine (20), the dimethylallyl derivative will 
act as a precursor in and undergo an analogous series of reactions (Fournet et 
al. 1993; Paul 2002).   
 
NH O
OH
OPP
C-alkylation
4-hydroxy-2-quinolone
    
NH O
OH
SAM
NH
OMe
O
Cyclization on to 
dimethylallyl side-chain;
consider involvement of
hydroxyimine tautomer
N O
 OH
 OMe
O
OMe
OMe
OMe
      Skimmianine (20) 
(17) (18)
(19)
 
Figure 2.6 Biosynthetic pathway of furoquinoline/skimmianine (20) (Paul 
2002).    
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Two new alkaloids were reported in the literature search, for instance 
2-6-(2H-benzo[d]1,3-dioxolen-5-yl)hexyl-hydroquinolin-4-one and 2-
{6’(2Hbenzo[d]1”, 3”-dioxolen-5”yl)hexyl}-4-methoxy-quinoline. These 
were yielded from R. chalepensis, collected from the northern Saudi desert. 
Another alkaloids from this plant are dictamnine, pteleine, skimmianine, 
isogravacridonechlorine, maculosidine, graveoline, graveolinine, and              
4-methoxy-1-methyl-2(1H)-quinolinone, and chalepensin (Emam et al. 2010).  
  
2.2.2 Antifungal Active Alkaloids 
 
         A lot of studies have been conducted for so many years regarding 
phytochemical and pharmacological activities of  materials extracted from 
members of the Rutaceae family (Adamska-Szewczyk et al. 2016). In such 
work, anthranillic acid derived alkaloids of the Rutaceae is taking one of the 
most attended due to their widened variety of medicinal application for 
instance antimicrobial, antiviral, antitumor and also analgesic effects (Sandjo 
et al. 2014). The literature search of this study has revealed a few Rutaceaea 
alkaloids which have completed phytochemical analysis, isolated and fully 
identified with antibacterial and antifungal properties. The focus is more 
towards the bioactivity of acridone, furoquinolines and 4-quinolone alkaloids. 
Previously isolated alkaloids from R. angustifolia includes dictamnine, 
skimmianine, kokusaginine (Adamska-Szewczyk et al. 2016), berberine 
(Alam et al. 2011), rutaverine, arborinine, rutin, xanthotoxin, fagarine and 
graveolinine (Strigácová et al. 2000).  The alkaloid berberine produced by 
Ravenia spectabilis from Rutaceae has an inhibitory activity against             
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C. albicans (Pepeljnjak & Petricic, 1992). Two fractions containing 
skimmianine and arborinine obtained from R. angustifolia of hexane and 
acetone extracts were screened for antifungal activity and reported to exhibit 
activity against C. albicans (Zarisa, 2013).         
    Besides Ruta angustifolia, Ruta graveolens is another popular species 
among Rutaceae family native to Mediterranean region but widely distributed 
all over the tropical regions. The searched for their antimicrobial activities 
were based on ethanolic, methanolic, chloroform and water extracts from the 
stem of the plant. By implementing agar-disc diffusion assay, each extract 
were then tested for anti-fungal activity against Aspergillus niger, 
Aspergillus.  flavus,  Penicilium crysogenum, Rhizopus stolonifer and 
Fusarium oxosporium. Out of the four extracts, ethanolic stem extract 
demonstrated the most pronounced inhibition of growth while the rest showed 
moderate antifungal activity except against Flasparum oxosporium (Pandey 
et al, 2011).  
 
2.4 Virulence and Pathogenicity of Fungal Pathogen 
 
Candidiasis is a common fungal infection that generally inhabit and 
localized the skin, fingers, oral cavity, esophagus, bronchi, lungs, 
gastrointestinal tract and vagina (Calderone et al. 2014). The most frequently 
identified species are C. albicans (70%) and C. glabrata (7%) (Pfaller et al. 
2002). The condition is usually benign in healthy individual but can become 
infectious with widely range clinical syndrome from non-life threatening 
mucocutaneous illnesses to invasive progressions of bloodstream if immune 
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system are impaired or environmental niche of the host are disturbed (Pappas et 
al. 2004). Environmental niche is basically the local environment of the host 
which includes the interaction of normal microbiome that interrelate with 
hormones, diet and immune responses. There are presence of symbionts, which 
is the microbes that support health, commensals with no actual benefits to the 
host and pathobionts, a permanent resident with possibility to become 
pathogenic. In HIV-infected patients for instance, they often have low levels of 
Bifidobacteria and Lactobacilli species in the gut which allowed C. albicans to 
inhabit and become pathogenic (Salas & Chang 2014).  
The ability of Candida to colonize the epithelial surfaces and to adapt 
the tissue environment of the host are prerequisite for pathogenesis 
development (Kobayashi et al. 2006). There are two types of infections which 
are superficial and invasive candidiasis. Superficial infection, include oral and 
vaginal thrush and also chronic mucocutaneous candidiasis. This type of 
infection is usually non-lethal, but still it significantly lowers the quality of life 
(Bondaryk et al. 2013).      
Invasive candidiasis on the other hand normally occur once epithelial 
tissues are breached and enter the blood stream which termed as candidemia 
(Perlroth et al. 2007). This will further lead to systemic candidiasis, 
characterized by haematogenous spread to one or more vital organ such as 
kidney, liver, spleen and brain (Ahmad et al. 2010; Hashim et al. 2012).     
Severity of candidiasis depends on factors such as size of inoculum, ability of 
fungi to multiply in the tissue, magnitude of tissue damages and immune status 
of the host cells (Sajjad et al. 2010). A published literature has suggest that 
inoculum size of the cells in patients with candidemia is 104 CFU/ml and       
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103 CFU/ml  of blood for C. albicans and C. glabrata respectively (George et 
al. 2005).   
Dimorphic properties of Candida allow them to be able to multiply in 
the host tissue whereby transition between yeast and filamentous forms is often 
stimulated by growth within the host and can be observed in infected tissues 
during infection (Mayer et al. 2013; Chin et al. 2016). Magnitude of tissue 
damage is also due to this filaments formation in which they can escape from 
macrophages killing (Chin et al. 2016). C. glabrata on the other hand, is 
strictly haploid and normally grows only in the yeast form (Kaur et al. 2005).  
Immune status of the host cells also contributed to the severity of the infection 
where in normal condition, Candida will be phagocytosed by macrophages and 
neutrophils that secretes cytokines and induce hyphal development. Thus, in 
neutropenic patients, deficient in these immune cells will particularly lead to 
systemic candidiasis (Lorenz & Fink 2001). Overall, these factors contribute to 
the pathogenicity of fungal infection and often referred to as virulence factor. 
Virulence factors are of pronounced interest in fungal pathogenesis because 
they are often the target of the immune response (Casadevall & Pirofski 1999). 
For example, upon phagocytosis by macrophages, C. albicans undergoes a 
massive metabolic reorganization activating genes involved in alternative 
carbon metabolism including the glyoxylate cycle and gluconeogenesis 
(Brown, Brown, et al. 2014) which will be explain later in this chapter. Besides 
metabolic adaptation, Candida also possesses a range of virulence attributes 
including adherence to epithelial and endothelial cells, proteinase and 
phospholipase production, hypha and pseudohypha formation, phenotypic 
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switching, and antigenic modulation as a result of pseudohypha formation 
(Ahmad et al. 2010).         
Like other Candida species, C. glabrata is a part of the normal 
microbiota of the mouth, gastrointestinal and vaginal tracts in humans and, in 
healthy individuals, it does not cause disease. However, C. glabrata becoming 
a cause for disease when there is disturbances in the normal environment 
especially in immunosuppressed hosts (Rodrigues 2013). However, the 
virulence factors associated with C. glabrata, relative to other pathogenic yeast 
species like C. albicans are poorly understood. Though, there is agreement that 
pathogenicity of C. glabrata could be attributed to its ability to form biofilms, 
inability to form true hyphae and to secrete certain proteases (Tam et al. 2015; 
Rodrigues 2018). Instead, C. glabrata continues to replicate as yeasts inside the 
phagosome until the host cell bursts by an unknown mechanism (Seider et al. 
2011). Compared with C. albicans, C. glabrata can sometimes be considered 
to be less virulent (Fidel & Vazquez 1999).      
Candidiasis provide a range of symptom which is depending on the site 
of infection and the degree of immunosuppression. Patients may be 
asymptomatic or experiencing dysphagia, odynophagia, retrosternal pain, 
epigastric pain, nausea and vomiting. If the case of Candidemia, they may have 
fever, chills, skin rash, fatigue, low blood pressure, muscle aches, vision 
changes, headaches and neurological deficit (Pappas et al. 2004; Ahmad et al. 
2010).  
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2.5 Metabolism in Pathogenesis of Candida 
 
Candida albicans and Candida glabrata, are among the successful 
pathogen due to their metabolic adaptation on the available nutrients. They are 
able to multiply under both nutrient-rich and nutrient-poor conditions (Ende et 
al. 2019).  The fundamental essential for the Candida to grow and survive is 
nutrient and carbon assimilation (Calderone & Fonzi 2001). Once they inhabit 
a dynamically contrast niches, adaptation in availability of nutrient will take 
place to enhances the fitness of the fungus. This is very important for 
pathogenicity as virulence factors, thereby signifying an attractive target for 
potential therapeutic intervention (Ene et al. 2014). As mentioned previously, 
Candida responded to phagocytosis of macrophages by inducing pathways 
required for alternative carbon metabolism namely gluconeogenesis, glyoxylate 
cycle and fatty acid β-oxidation. Obviously, these pathways are important for 
their survival in the macrophage which try to kill them off by oxidative burst 
and low nutrient availability (Lorenz & Fink 2001; Rodaki et al. 2009).  
The pathway relies on the efficient uptake and metabolism of available 
carbon sources which include fermentable sugars (such as glucose, fructose, 
and galactose) and non-fermentable carbon sources (such as amino acids and 
organic acids) (Fernando & Ludovico 2005). Analysis of fungal cells from 
different infection models showed that the carbon metabolism pathways are 
activated in mucosal and intraperitoneal infection models (Thewes et al. 2007) 
and were thought to reflect the heterogeneous nature of fungal populations in 
complex host microenvironments, whereby phagocytosed cells that are 
exposed to carbon starvation activate the glyoxylate cycle, whereas non-
21 
 
phagocytosed cells retain access to glucose and activate glycolysis (Brown, 
Brown, et al. 2014).  
 
2.5.1 Glycolysis and gluconeogenesis 
 
Glycolysis is a sequence of reactions in Candida involves the 
conversion of one molecule of glucose into two-molecules of pyruvate. This is 
a conserved metabolic pathway, consists of the anaerobic conversion of 
glucose to pyruvate with the net production of two molecules of ATP (Figure 
2.7). Pyruvate generated by glycolysis may be fermented to ethanol, or may 
enter the TCA cycle under aerobic conditions to generate additional energy and 
biosynthetic precursors (Eschrich et al. 2002).   
This pathway, occurs in two phases, consist of phosphorylation of 
glucose to generate two molecules of glyceraldehyde-3-phosphate followed by 
conversion of glyceraldehyde-3-phosphate to pyruvate (Barelle et al. 2006). 
Prior to glycolysis, glucose enters cells and is phosphorylated by ATP to form 
glucose-6-phosphate. The next step in glycolysis is the isomerization of 
glucose 6-phosphate to fructose 6-phosphate. Fructose 6-phosphate is then 
phosphorylated by ATP to fructose-1, 6-bisphosphate (F-1, 6-BP). The second 
stage of glycolysis begins with the splitting of fructose 1,6-bisphosphate into 
glyceraldehyde-3-phosphate (GAP) and dihydroxyacetone phosphate (DHAP) 
which are interconverted by triphosphate isomerase. The final phase in the 
glycolytic pathway involve the conversion of phosphoenolpyruvate (PEP) into 
pyruvate which is catalysed by pyruvate kinase. The products consist of three-
carbon units rather than six-carbon units (Fernando & Paula 2005).     
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 Gluconeogenesis on the other hand is the generation of glucose from 
non-sugar carbon substrates such as pyruvate, lactate, glycerol, and 
gluconeogenic amino acids. The process is essentially the reversal of the 
glycolysis pathway but not the exact reverse of glycolysis, some of the steps 
are the identical in reverse direction and three of them are new ones (Figure 
2.11). The starting point of gluconeogenesis is pyruvic acid, although 
oxaloacetic acid and dihydroxyacetone phosphate also provide entry points. 
Notice that oxaloacetic acid is also the first compound to react with acetyl CoA 
in the tricarboxylic acid cycle (TCA). Two essentially irreversible steps of the 
glycolytic pathway, which are catalysed by phosphofructokinase and pyruvate 
kinase, must be bypassed during gluconeogenesis. Fructose-1,6-biphosphate 
(encoded by FBP1 gene) catalyses the reverse reaction to phosphofructokinase. 
Meanwhile, phosphoenolpyruvate carboxykinase (encoded by PCK1 gene) 
generates phospoenolpyruvate from oxaloacetate thereby passing pyruvate 
kinase (Eschrich et al. 2002). Therefore, any compounds that can down 
generate PCK1 gene, may stop the Candida from growing and inhabit the host.  
Both glycolysis and gluconeogenesis take place in the cytosol however, 
several enzymes of these pathways are also present in the cell wall (Urban et 
al. 2003). Similar to C. albicans, changes in gene expression was found in 
consistent with severe carbohydrate deprivation, including upregulation of 
genes in the glyoxylate cycle, beta-oxidation of long-chain fatty acids, and 
gluconeogenesis after incubation of C. glabrata with neutrophils (Fukuda et 
al. 2013).  
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Figure 2.7 Substrates and enzymes involved in Glycolysis and gluconeogenesis 
pathway in Candida which take place in cytosol (Dwong, 2018).      
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2.5.2 The Tricarboxylate Acid (TCA) cycle and Glyoxylate cycle 
 
The ubiquitous tricarboxylic acid (TCA) cycle, the second stage of 
respiration after glycolysis is a central pathway for the metabolism of carbon 
sources, lipids, and amino acids, and generate a major energy source for the 
cell under aerobic conditions (Tao et al. 2017). Basically, TCA cycle (Figure 
2.8) consumes two-carbon units in the form of acetyl-CoA which is formed 
from pyruvate by the pyruvate dehydrogenase complex under oxidative and 
non-pressing conditions. This is the part that link between glycolysis and the 
TCA cycle. Acetyl-CoA and oxaloacetate are catalysed by citrate synthase in 
the formation of citrate. Citrate is then oxidized by a series of reactions to yield 
two molecules of CO2 and one oxaloacetate. The energy generated by this 
oxidation is mainly occur in the mitochondrial matrix and conserved in the 
form of reducing equivalences NADH and FADH2 (Kruckeberg & Dickinson 
1999; Lee et al. 2011).     
The function of TCA cycle is to provide reducing equivalents to the 
respiratory chain (Lorenz & Fink 2001; Fernando & Ludovico 2005) and also 
plays key roles in generating metabolic intermediates for various biosynthesis 
pathways and in catabolising of products from other pathways. These include 
fatty acid β-oxidation, the catabolism of the amino acids isoleucine, methionine 
or valine, and the transamination and deamination of other amino acids thereby 
generating oxaloacetate and α-ketoglutarate (Lorenz & Fink 2001). A recent 
proteomics study indicates that the TCA cycle is involved in the control of 
antifungal tolerance and biofilm formation (Li et al. 2015).  
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However, when Candida is grown on two-carbon compounds, such as 
acetate, the TCA cycle by itself cannot supply adequate amounts of 
biosynthetic precursors unless alternative reactions are available. Therefore, 
they employs a modification of the TCA cycle called the glyoxylate cycle 
(Figure 2.8). In this cycle, two-carbon acetate units are convert into          four-
carbon dicarboxylic acids by bypassing oxidative decarboxylation during 
which they are incorporated into new molecules of glucose. The glyoxylate 
cycle regulates macrophage phagocytosis and virulence of            C. albicans, 
whereby disruption of this prevents the growth of C. albicans inside 
macrophages by blocking nutrient availability (Lee et al. 2011).    
Following phagocytosis by macrophages or neutrophils of the infected 
host, cytokines were secreted and hyphal-development occurred in the fungi. 
The glyoxylate cycle enables fungi to survive and grow in the nutrient-limited 
environment inside the phagocytic cells by utilizing alternative carbon sources 
such as lipid and amino acids (Lorenz & Fink 2001). Isocitrate lyase (ICL1) 
and malate synthase (MLS) are the key enzymes for this pathway which are 
highly conserved in bacteria, fungi and plants (Dunn et al. 2009).  
